Scientists at Cincinnati Children’s Hospital Medical Center have identified a missing piece of the puzzle of how lung damage occurs in cystic fibrosis (CF). CF is a life-threatening, genetic disease that causes chronic lung infections and impairs digestion. The discovery, published in the current issue of Nature Immunology, provides impetus for the development of novel therapeutics that decrease inflammation in children with CF.
